TheEdgeResearch
Home / Stocks / ROMJF

Rubicon Organics Inc. (ROMJF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.24 ▲ +3.04%
Market Cap
$16.3M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.38
52-Wk Range
0.2277-0.44
CEO
Margaret Ruth Brodie
Country
CA
Currency
USD

Rubicon Organics Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.24, up 3.04% on the session, giving a market capitalisation of $16.3M. On trailing twelve-month figures it carries a trailing P/E of -5.26, a net margin of -7.0%. Its beta of 0.38 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-5.26
Price / Sales
0.35
Price / Book
0.58
EV / EBITDA
-2.02
Gross margin
-10.8%
Operating margin
-32.3%
Net margin
-7.0%
Return on equity
—
Debt / equity
0.36
Current ratio
1.96
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
266
IPO date
2018-10-24
Headquarters
Vancouver, BC, CA
About Rubicon Organics Inc.

Rubicon Organics Inc. cultivates, processes, and distributes organic cannabis products for both recreational and medicinal consumers across Canada. The company markets its organic cannabis through its proprietary labels as well as various licensed brands. Founded in 2015, Rubicon Organics Inc. maintains its headquarters in Vancouver, Canada.

Comparable companies

Rubicon Organics Inc. is most often compared with the following Healthcare names:

AVCNFCAAOFCNTMFCWBHFEOFBFGBLPHSTIISCNFMEDIFVYYRF
More research on ROMJF
ROMJF technical analysis ROMJF TheEdge Score Compare against peers
Open full interactive analysis & DCF →